Compare RNA & AMRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | AMRO |
|---|---|---|
| Founded | 2025 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 166.1M |
| IPO Year | 2025 | 2026 |
| Metric | RNA | AMRO |
|---|---|---|
| Price | $6.45 | $5.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $22.00 | $13.18 |
| AVG Volume (30 Days) | 205.6K | ★ 373.8K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $104.53 | $520.53 |
| Revenue Next Year | N/A | $49.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.47 | $3.99 |
| 52 Week High | $73.06 | $8.64 |
| Indicator | RNA | AMRO |
|---|---|---|
| Relative Strength Index (RSI) | 24.72 | 54.65 |
| Support Level | N/A | $5.20 |
| Resistance Level | $8.50 | $6.55 |
| Average True Range (ATR) | 0.42 | 0.64 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 1.49 | 35.81 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Amaero Inc specializes in manufacturing high-performance powders and near-net-shape components using additive manufacturing and HIP technologies, ensuring precision, material integrity, and reduced times for critical applications. It serves in industries of Aerospace, Defense, Energy, Oil & Gas, and Others. The group leverages cutting-edge gas atomization and hot isostatic pressing (HIP) technologies to create high-performance components that reduce porosity and improve material integrity. Its focus is on reshoring critical materials production and defense manufacturing, offering high-value refractory, specialty, and titanium alloyed powders.